Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

AIDS Clinical Trials Group

Kieburtz K, Simpson D et al (1998) A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology... [Pg.81]

Martin C, Solders G et al (2000) Antiretroviral therapy may improve sensory function in HIV-infected patients a pilot study. Neurology 54(11) 2120-2127 Masjuan J, Corral I et al (1997) Mycobacterial acute lumbosacral polyradiculopathy as the initial manifestation of AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 15(2) 175 McArthur JC, Yiannoutsos C et al (2000) A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 54(5) 1080-1088... [Pg.81]

Yen-Lieberman, B et al. (1996). Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type I RNA in plasma by the AIDS Clinical Trials Group Virology Laboratories. J. Clin. Microbiol. 34,2695-2701. [Pg.235]

HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. Ann Intern Med 1999 130(6) 510-514. [Pg.97]

Collier AC, Coombs RW, Schoenfeld DA, Bassett RL. et al. 1996. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS clinical trials group. N Engl J Med 334 1011-1017. [Pg.197]

Connor EM, Sperhng RS, Gelber R, Kiselev P, et al. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group protocol, 076 study group. NEJM. 331 1173-1180. [Pg.197]

Dohn R, Amato DA, Fischl MA, Pettinelli C, et al. 1995. Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trial Group. Arch Int Med. 155 961-974. [Pg.197]

Hammer SM, Kaizen stein DA, Hughes MD, Gundacker H, et al. 1996. A trial comparing nucleoside monotherapy with combination therapy in HIV infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS clinical trials group study, 175 study team. NEJM. 335 1081-10990. [Pg.198]

McCance-Katz EF, Rainey PM, Jatlow P, et al. Methadone effects on ZDV disposition (AIDS Clinical Trials Group 262). J Acquir Immune Defic Syndr Hum Retroviral 1998 18(5) 435 t43. [Pg.123]

Pfister M, Labbe L, Lu JF, Hammer SM, Mellors J, Bennett KK, Rosenkranz S, Sheiner LB, AIDS Clinical Trial Group Protocol 398 investigators. Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir. Clin Pharmacol Ther 2002 72 133 11. [Pg.224]

Hochster H, Dieterich D, Bozzette S et al. Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS An AIDS clinical trials group study. Ann Intern Med 1990 113 111-17. [Pg.244]

Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, Millar LL, Colquhoun D, Lenkinski R, Gonzalez RG, Lipton SA (2007) Adult AIDS Clinical Trial Group (ACTG) 301 700 Teams HIV MRS... [Pg.618]

Sidds JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, Simpson D, Koch MA, Feinberg J, Dafni U, The AIDS Clinical Trials Group (1993) Zidovudine treatment of the AIDS demenda complex Results of a placebo-controlled dial. Ann Neurol 33 343—349. [Pg.620]

Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl JMed 1995 332(ll) 700-5. [Pg.304]

Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. N Engl J Med... [Pg.369]

Jabs DA, Freeman WR, Jacobson M, Murphy R, Van Natta ML, Meinert CL. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. AIDS 2000 14(11) 1571-81. [Pg.772]

McIntosh K, Cooper E, Xu J, Mirochnick M, Lindsey J, Jacobus D, Mofenson L, Yogev R, Spector SA, Sullivan JL, Sacks H, Kovacs A, Nachman S, Sleasman J, Bonagura V, McNamara J. Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group. Pediatr Infect Dis J 1999 18(5) 432-9. [Pg.1052]

Krown SE, Li P, Von Roenn JH, Paredes J, Huang J, Testa MA. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi s sarcoma a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res 2002 22(3) 295-303. [Pg.1114]

Lewis RA, Clogston P, Fainstein V, et al. Morbidity and toxic effects associated with ganciclovir or foscamet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med I995 I55(I) 65-74. [Pg.1448]

Melvin AJ, Borkowsky W, Petru A, Kovacs A, Yogev R, Goldsmith J, McFarland EJ, Spector S A. Oral ganciclovir in children pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group. J Infect... [Pg.1482]

Concern about the toxicity of hydroxycarbamide, expressed in a report from the AIDS Clinical Trials Group (ACTG 5025 report), has led to a retrospective study of the antiviral activity, immunological effects, and... [Pg.1703]

Krogstad P, Lee S, Johnson G, Stanley K, McNamara J, Moye J, Jackson JB, Aguayo R, Dieudonne A, Khoury M, Mendez H, Nachman S, Wiznia A, Ballow A, Aweeka F, Rosenblatt HM, Perdue L, Frasia A, Jeremy R, Anderson M, Japour A, Fields C, Farnsworth A, Lewis R, Schnittman S, GigUotti M, Maldonaldo S, Lane B, Hernandez JE, et al. Pediatric AIDS Clinical Trials Group 377 Study Team. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nehinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1. CUn Infect Dis 2002 34(7) 991-1001. [Pg.2590]

Japour AJ, Lertora JJ, Meehan PM, Erice A, Connor JD, Griffith BP, Clax PA, Holden-Wiltse J, Hussey S, Walesky M, Cooney E, Pollard R, Timpone J, McLaren C, Johanneson N, Wood K, Booth D, Bassiakos Y, Crumpacker CS. A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team. J Acquir Immune Defic Syndr Hum Retrovirol 1996 13(3) 235-46. [Pg.3038]

Para MF, Finkelstein D, Becker S, Dohn M, Walawander A, Black JR. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia AIDS Clinical Trials Group 268. J Acquir Immune Defic Syndr 2000 24(4) 337 3. [Pg.3523]

Levin MJ, Gershon AA, Weinberg A, Blanchard S, Nowak B, Palumbo P, Chan CY AIDS Clinical Trials Group 265 Team. Immunization of HIV-infected children with Varicella vaccine. J Pediatr 2001 139(2) 305-10. [Pg.3609]

See other pages where AIDS Clinical Trials Group is mentioned: [Pg.201]    [Pg.225]    [Pg.264]    [Pg.555]    [Pg.718]    [Pg.277]    [Pg.613]    [Pg.618]    [Pg.618]    [Pg.368]    [Pg.370]    [Pg.773]    [Pg.1391]    [Pg.1639]    [Pg.2971]    [Pg.3227]    [Pg.3578]   
See also in sourсe #XX -- [ Pg.277 ]



SEARCH



© 2024 chempedia.info